Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

The Development of Novel Digital Endpoints

Session Chair(s)

Michelle  Crouthamel, PhD

Michelle Crouthamel, PhD

Head, Digital Science

AbbVie, United States

This session will be used to present two examples of novel digital endpoint development with live chat and Q&A discussion to follow.

Learning Objective : Discuss the novel digital development framework through industry examples; Identify the concept of interest, the context of use, and the design of validation will be included.

Speaker(s)

Robert  Mather, PhD

Itching for Feedback: Framework for Qualifying Novel Digital Outcomes

Robert Mather, PhD

Pfizer Inc, United States

Executive Director, Early Clinical Development

Rinol  Alaj, MBA

The Development of Novel Digital Endpoints

Rinol Alaj, MBA

Regeneron Pharmaceuticals, United States

Director, Clinical Outcomes - Assessments and Innovation

Sara  Hamon, PhD

The Development of Novel Digital Endpoints

Sara Hamon, PhD

Regeneron, United States

Director, Precision Medicine Quantitative Translational Sciences

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.